Summary
Definition
History and exam
Key diagnostic factors
- estação do inverno
- surto atual de gripe
- não vacinado
- tosse com febre
Other diagnostic factors
- faringite
- linfadenopatia cervical
- dispneia
Risk factors
- idade ≥65 anos
- 6-59 meses de idade
- doenças cardiovasculares ou respiratórias crônicas
- diabetes
- hemoglobinopatia
- estado imunocomprometido
- doença renal crônica (DRC)
- gestação
- cuidadores e contactantes domiciliares de grupos de alto risco
- profissionais da saúde
Diagnostic tests
1st tests to order
- diagnóstico clínico
Tests to consider
- ensaios moleculares
- testes de detecção de antígeno
- cultura viral
- sorologia
- radiografia torácica
Treatment algorithm
exposição a indivíduo(s) infectado(s) em população de risco
adultos
crianças
Contributors
Authors
Kyle Eggleton, MBChB PhD FRNZCGP(Dist)
Associate Dean Rural
Department of General Practice and Primary Health Care
University of Auckland
Auckland
New Zealand
Disclosures
KE declares that he has no competing interests.
Rachel Roskvist, MBChB, FRNZCGP, MHSc
Senior Lecturer
Department of General Practice and Primary Health Care
University of Auckland
Auckland
New Zealand
Disclosures
RR declares that she has no competing interests.
Bruce Arroll, MBChB PhD FRNZCGP
Department of General Practice and Primary Health Care
University of Auckland
Auckland
New Zealand
Disclosures
BA declares that he has no competing interests.
Acknowledgements
Dr Kyle Eggleton, Dr Rachel Roskvist, and Professor Bruce Arroll would like to gratefully acknowledge Dr Cristine Radojicic, a previous contributor to this topic.
Disclosures
CR declares that she is on Advisory boards for CSL Behring and Speakers Bureau Biocryst.
Peer reviewers
Michael Ison, MD
Chief
Respiratory Diseases Branch
National Institute of Allergy and Infectious Diseases
Bethesda
MD
Disclosures
MI declares that he has no competing interests.
Waleed Javaid, MD, FACP, FIDSA
Associate Professor
Medical Director of Infection Control
Infectious Disease
Department of Medicine
SUNY Upstate Medical University
Syracuse
NY
Disclosures
WJ declares that he has no competing interests.
Rachel L. Miller, MD, FAAAAI
Associate Professor of Clinical Medicine and Environmental Health Sciences
Columbia University College of Physicians and Surgeons
New York
NY
Disclosures
RLM declares that she has no competing interests.
Mark Sands, MD, FAAAAI
Chief
SUNY Buffalo School of Medicine
Division Allergy and Immunology
Buffalo
NY
Disclosures
MS declares that he has no competing interests.
An De Sutter, MD, PhD
Associate Professor
Department of General Practice and Primary Health Care
Ghent University
Ghent
Belgium
Disclosures
ADS declares that she has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019 Mar 5;68(6):e1-47.Full text Abstract
Centers for Disease Control and Prevention. Influenza (flu). Feb 2024 [internet publication].Full text
Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season. Aug 2024 [internet publication].Full text Abstract
UK Health Security Agency. Annual flu programme. May 2025 [internet publication].Full text
Centers for Disease Control and Prevention. Child and adolescent immunization schedule by age (addendum updated July 2, 2025): recommendations for ages 18 years or younger, United States, 2025. Jul 2025 [internet publication].Full text
Centers for Disease Control and Prevention. Adult immunization schedule by age (addendum updated July 2, 2025): recommendations for ages 19 years or older, United States, 2025. Jul 2025 [internet publication].Full text
Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. Dec 2023 [internet publication].Full text
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Doença do coronavírus 2019 (COVID-19)
- Pneumonia bacteriana
- Infecção por rinovírus
More DifferentialsGuidelines
- Statement on seasonal influenza vaccines for 2025-2026
- Child and adolescent immunization schedule by age: recommendations for ages 18 years of younger, United States, 2025
More GuidelinesPatient information
Gripe
Antibióticos: o que você precisa saber
More Patient information
Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer